(related to Figure 1) . Characterization of Ad5-K5-Cre and Ad5-K14-Cre both in vitro and in vivo. (A) Fluorescent images of mouse keratinocytes isolated from mT/mG reporter mice at P0 and collected 48 hr upon infection with 100 MOI of the indicated Cre Adenoviruses: Ad5-CMV-Cre is used as positive control of infection and Ad5-SPC-Cre is used as negative control of infection; both Ad5-K14-Cre and Ad5-K5-Cre enable keratinocytes to switch from Tomato to GFP. (B) MEFs isolated from mTmG mice and collected 48 hr upon infection with either Ad5-CMV-Cre or Ad5-K14-Cre. (C) Immunoblotting analysis of protein extracts isolated from keratinocytes 48 hr upon infection with the indicated adenoviruses and incubated with GFP antibody. Actin is used to normalize the protein levels. (D) Dual IF with GFP/K14, GFP/K5, GFP/CC10, performed on tracheas isolated from mTmG mice 7 days following Ad5-K14-Cre and Ad5-K5-Cre infection; mice were administered naphthalene (250 mg/kg) 3 days prior to adenovirus infection. (E) Dual IF with GFP/K14, performed on tracheas isolated from mTmG mice 21 days following Ad5-K14-Cre infection; mice were administered naphthalene (250 mg/kg) or vehicle (corn oil control) 3 days prior to adenovirus infection. Figure S2 (related to Figure 3 and Figure 4) . Generation of the conditional mice LSL-Fgfr1 K656E and LSLSox2 (A) Schematic representation of the Flp-recombinase mediated cassette exchange technology: in the first step a cassette containing PGK-Neomycin (PGK-Neo) and flanked by FRT sites was targeted to the Col1a1 locus by homologous recombination; in the second step, a minicircle DNA containing the cDNA of either SOX2 or FGFR1 K656E followed by a reporter protein (respectively CFP and YFP) was transfected in ES cell clones positive to the first targeting, together with Flip recombinase, which mediated the cassette exchange. (B) Southern blotting of BglII digested genomic DNA, isolated from ES cells and hybridized to the "Col1a1 3' probe", which is a 842 bp genomic fragment that anneals to a fragment of 1kb in wild-type (WT) mice (Line 1 and 2) and to a fragment of 4.9 kb in mutant (MUT) mice. 
Supplemental Experimental Procedures

Mouse generation
We targeted FVB ES cells with a vector containing a Flp-in module just after the 3′UTR of the Col1a1 locus (Beard et al., 2006) . This module, named Col1A1-frt, serves as a docking site for introduction of transgenecoding plasmids by Flp recombinase-mediated integration. The vector contained also a PGK-Neomycin cassette for positive selection of ES clones. The Col1A1-frt targeted GEMM-ESC clones were subsequently injected into morulae or blastocysts to produce chimeric mice to assess their transmittability. Both injected ES clones produced germline competent chimeras. In the second step, a transgenic construct was introduced in the Col1A1-frt locus of germline competent ES clones, using the Flp recombinase. The transgenic construct was carried by a minicircle DNA, devoid of bacterial elements (S2A). It has been previously demonstrated that bacterial DNA linked to a mammalian expression cassette resulted in transcriptional silencing of the transgene (Chen et al., 2004) . The two transgenic constructs we used to generate LSL-Sox2 and LSL-Fgfr1 K656E , were called Sox2-frt-invCAG and Fgfr1-frt-invCAG, respectively. They contained the cDNA of either SOX2 or FGFR1, which, following Cre mediated inversion is expressed from a constitutive CAG promoter ( Figure S2A ). Before the inversion the transgene is flanked by a Lox-stop-Lox cassette. For identification of cells in which recombination had occurred, we inserted an IRES followed by a fluorescent protein: YFP to track FGFR1 expression and CFP to track SOX2 expression ( Figure S2C ). We introduced a mutation in the cDNA of FGFR1 (K656E) which results in its activation in the absence of ligand (Jin et al., 2003) . These vectors were introduced into a Col1A1-frt targeted FVB ES cells with 100% efficiency. Colonies were screened by PCR and correctly targeted clones were confirmed by Southern blotting ( Figure  S2B ). The Col1a1 locus has been shown to allow for ubiquitous expression of transgenes when combined with the CAGGS promoter ( Figure S2A ) (Huijbers et al., 2014) . Correctly recombined ES cell clones were treated with a permeable Cre-recombinase in order to validate the activation of FGFR1 or SOX2 expression ( Figure S2C left panel) . ES cells also expressed the fluorescent protein, as indicated by confocal images (Figure S2C right panel) . To exclude that any rearrangement had occurred in vivo, MEFs were isolated from E13.5 embryos obtained by crossing LSL-Sox2 mice with Rosa26-CreERT2 mice, and treated with Tamoxifen, to switch on the expression of the transgene. Both SOX2 and CFP were expressed in MEFs carrying the transgene only upon Tamoxifen treatment, as assayed by real time RT PCR ( Figure S2E ). WT MEFs were obtained from mT/mG E13.5 embryos as control of expression of the fluorescent protein ( Figure. S2E ).
Generation of tissue specific Cre Adenoviruses
In order to target basal cells we utilized adenoviral vectors carrying a Cre-recombinase gene whose expression is driven either by a DNA fragment containing the 2 kb human K14 promoter, or the 5.2 kb of upstream 5' flanking and promoter sequences from the bovine K5 locus (pHR2 plasmid generously provided by Sabine Werner). The Cre open reading frame with an N-terminal synthetic intron and C-terminal polyadenylation signal was isolated from pOG231 (O'Gorman et al., 1997) and inserted in pDONR TM 221 under the described K5 and K14 promoters, previously inserted in the same vector. Cloned pDONR TM 221 constructs were then recombined into promoter-less pAd-PL DEST vectors (Invitrogen) by Gateway LR recombination, to generate Ad5-K5-Cre and Ad5-K14-Cre adenoviral constructs. High titer adenoviruses were amplified and purified for use in vivo by the University of Iowa Gene Transfer Vector Core, supported in part by the NIH and the Roy J. Carver Foundation, for viral vector preparation.
Cell culture
Newborn mouse skin was isolated from mT/mG mice and then placed in dispase o/n at 4 °C. The day after keratinocytes were isolated from epidermis by enzymatic dissociation in trypsin, and cultured in defined CnTPrime Epithelial cell culture medium (CnT07, CELLnTEC) as described previously (Strachan et al., 2008) . Once attached, they were infected with 100 MOI and analyzed for GFP expression 48 hours upon infection. Fluorescent signals were monitored under a Leica CTR6000 image microscope. Protein extracts were also collected and samples were analyzed by immunoblotting with anti-GFP antibodies. MEFs were isolated from 13.5 postcoitum (p.c.) mouse embryos of either mT/mG;CreERT2 or LSLSox2;CreERT2 and LSL-Fgfr1 K656E ;CreERT2 mice. The embryos, after removal of internal organs, were dissociated and then trypsinized to produce single-cell suspensions. Cells were treated with 4-Hydroxytamoxifen (0.2mm) to switch on the expression of the transgenes. Total RNA was collected 48 hr upon treatment. RNA was extracted in TRIzol reagent (Invitrogen). Complementary DNA (cDNA) synthesis was obtained using SuperScript™ III Reverse Transcriptase (Invitrogen).
Real-time RT PCR was performed using the SYBR Green PCR master mix (Applied Biosystems) in the Applied Biosystems® StepOnePlus™ Real-Time PCR System. Expression of target genes was normalized for Actinb.
Gene expression profile analysis Data set
For mouse LADC, we used GSE61190 dataset, which contains 19 tumor samples isolated from Kras;p53 mice with and without Eed. RNAseq profiles for human primary tumor (LSCC and LADC) were obtained from The Cancer Genome Atlas (TCGA) dataset. Human LSCC was selected based on SOX2 amplification and deletion of PTEN, CDKN2A, CDKN2B (Table S4) .
Read mapping, assembly, and expression analysis After quality filtering according to the illumina pipeline, 51-bp single-end reads were mapped to the mouse genome (assembly NCBIM37.67), using TopHat (2.0.12) (Trapnell et al., 2009) . TopHat was run with default. Reads with mapping quality less than 10 and non-primary alignments were discarded. Remaining reads were counted using HTSeq-cout (Anders et al., 2015) . Statistical analysis of the differential expression of genes was performed using DESeq2 (Love et al., 2014) . Genes with False Discovery Rate (FDR) for differential expression lower than 0.05 were considered significant. Batch effect with in tumor samples from different source was corrected using ComBat with default options through the Bioconductor package sva 3.10 (Johnson et al., 2007; Leek and Storey, 2007) .
Determination of differentially expressed genes in mouse and human LSCC
To identify genes correlating with the phenotypic groups, fold changes of gene expression in mouse LSCC (6 samples) was compared to mouse LADC (8 samples) and human LSCC (18 samples) compared to human LADC (17 samples). Multiple hypothesis testing was corrected for using the Benjamini and Hochberg method (BH) (Benjamini et al., 2001) , and significantly differentially expressed genes are reported.
To identify genes correlating with the phenotypic groups, we used DESeq2 to compute the variance stabilized expression values between three groups: Basal SCC, Club SCC and AT2 SCC. The expression heatmap of tumor subtypes are plotted using unsupervised consensus clustering of the top 100 most variable genes. The genes with padj < 0.01 and log2fold change > 1 are considered to be significant.
Gene set enrichment and functional set enrichment analysis
Gene Set Enrichment Analysis (GSEA) (Subramanian et al., 2005) was used to investigate the correlation of gene set significantly overrepresented in the transcriptome of either mouse or human LSCC. Transcripts were ranked by the difference of classes (metric for gene ranking) and using the following settings: number of permutations = 1,000, permutation type = gene set, chip platform = Null, enrichment statistic = weighted, gene list sorting mode = real, gene list ordering mode = descending, max gene set size = 500, min gene set size = 15. The gene set were manually created specific for unregulated and downregualted genes in LSCC over LADC in both mouse and human tumor model. A gene set was identified as significantly enriched when associated with p value scores ≤ 0.05. Functional enrichment analyses were generated with the DAVID tool (Huang da et al., 2009) . The GO enrichment analysis was carried out in the "two lists mode", using the lists of DEGs and as background the corresponding list of expressed genes. Significant GO terms (p value<0.05) were mapped with the REViGO online tool (http://revigo.irb.hr) with default parameters except for the resulting list that was setting as small size, which removes redundant GO terms and visualizes the semantic similarity of remaining terms (Supek et al., 2011) . The results were visualized as bar charts.
